title: Commentary: IBD combination therapy - adalimumab plus immunosuppressants.
authors.affiliation: Head IBD Service, Royal Adelaide Hospital, Adelaide, Australia. Jane.Andrews@health.sa.gov.au
authors.forename: J M
authors.initials: JM
authors.lastname: Andrews
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha